drug pricing

A new Pioneer Institute study illustrates how the current system of drug pricing and discounts leads to patients with challenging diseases being charged huge out-of-pocket sums to keep other premiums low, effectively imposing financial penalties on the sick to protect the healthy and wealthy.

Value-based reimbursement, focus on middlemen in drug distribution system more likely to reduce prices, provide consumers with valuable information BOSTON – As Massachusetts lawmakers consider healthcare price transparency legislation, a new Pioneer Institute study finds that most new drug pricing transparency laws...